04/08/08: Aquapharm and Croda International sign three year research collaboration and license agreement:  This agreement provides Croda with an exclusive license to novel marine derived natural products, identified through the collaboration, for use in topical cosmetic applications in skin and hair care. MORE>>

09/07/08: Aquapharm and Dr. Reddy's Sign Commercial License Agreements:  The agreements are an extension to a prior research and development arrangement and allow for specific strains from within the Aquapharm microbial library to be used to generate commercial biocatalysts in the manufacture of pharmaceutical intermediates. MORE>>

Aquapharm CEO wins Ernst & Young Scottish Entrepreneur of the Year in healthcare: June 16th 2008

The award recognises Dr Mearns Spragg's entrepreneurial ambition in setting up Aquapharm as well as his pioneering and innovative work in developing new anitbiotic compounds MORE>>

Aquapharm strengthens board and management team: May 2008

Mr Douglas Thomson has been appointed as Aquapharm's new Commercial Director and Professor Axel Kleeman has joined the board as a Non-executive Director MORE>>

Founder wins prestigious Gannochy Innovation Award: Oct 15th 2007

Dr Andrew Mearns Spragg, founder of Aquapharm has won Scotlands top award for Innovation from the Royal Society of Edinburgh.  The Gannochy Innovation Award is an annual award which carries a prize of £50,000 along with a specially commissioned gold medal which will be used to further the development of the company's lead anti-infective candidates. MORE>>

Aquapharm secures second round investment of £4M: July 24th 2007

Aquapharm's technology has been backed by investments from Aescap Venture, Tate & Lyle Ventures along with further investments by Scottish Enterprise, NESTA and HIE Argyll and the Islands Enterprise MORE>>

Nexxus: June 13, 2007:
Aquapharm Bio-Discovery wins DTI support to search for anti-cancer agents from its diverse collection of marine microbes: MORE >>

SIMS Conference 2007:

Aquapharm R&D Manager, Dorothee Gotz, is to present at the Society for Industrial Microbiology annual meeting in Denver on the Commercialisation of Extremophiles: MORE>>

Aquapharm attracts Pharma interest at BIO 2007:

Aquapharm CEO, Andrew Mearns Spragg and Business Development Manager, Jason Cleaversmith took part in the bio-partnering events at BIO 2007 in Boston.  Significant interest was shown in the developing pipeline of anti-microbial candidates, sourced from marine microbes, and the company now has a number of agreements in place to explore potential partnerships and development programmes for its drug leads.